Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

TKPHF

Takeda Pharmaceutical (PK) (TKPHF)

Takeda Pharmaceutical Co Ltd (PK)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:TKPHF
DateHeureSourceTitreSymboleSociété
11/06/202412h23Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
05/02/202412h24Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
10/07/202312h35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
28/06/202312h36Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
23/06/202312h15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
15/05/202312h37Edgar (US Regulatory)Specialized Disclosure Report (sd)USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
07/02/202320h12Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
29/05/202012h27Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
03/03/202012h00Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
26/02/202012h10Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
14/11/201912h12Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
12/11/201915h51Edgar (US Regulatory)Amended Securities Registration (foreign Private Issuer) (f-4/a)USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
09/08/201912h29Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-4)USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
27/06/201912h43Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
14/02/201920h16Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
09/06/201517h06The Motley FoolObesity Drugs: Stocks to WatchUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
16/05/201517h04The Motley FoolOrexigen Therapeutics, Inc. Goes From Biotech Beauty to Dreadful DrugmakerUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
23/03/201520h25The Motley FoolWhy ImmunoGen Inc. is Soaring Higher TodayUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
23/03/201517h14The Motley FoolWhy ImmunoGen, Inc. is Soaring Higher TodayUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
13/12/201206h00OTC MarketsPiggyback QualifiedUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
13/11/201214h18OTC MarketsVenue ChangeUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
13/11/201206h00OTC MarketsTier ChangeUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
20/09/201211h00ZacksFDA Panel to Review Celgene Drug - Analyst BlogUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
 Showing the most relevant articles for your search:USOTC:TKPHF